UNCLAIMED
Ceva Santé Animale
Overview
Ceva Santé Animale, founded in 1999 and headquartered in France, operates within the manufacturing sector, specifically focusing on pharmaceuticals for animal health. With an employee base ranging from 5,001 to 10,000, the company has established itself as a significant player in the veterinary pharmaceutical industry. A key area of expertise for Ceva is poultry health, as evidenced by their involvement in the XXIIIrd World Veterinary Poultry Association Congress, scheduled for October 2025 in Kuching, Malaysia. The congress will highlight recent advancements in poultry health, showcasing scientific abstracts that cover diverse topics such as vaccination innovations, field efficacy of vaccines, epidemiological insights, and emerging threats to poultry health. The research emphasizes the importance of real-world evidence and practical applications in addressing the complexities faced by poultry professionals globally. Ceva's commitment to scientific rigor and collaboration with partners in the veterinary field underscores its role in advancing poultry health and addressing challenges in the industry.